Click here to get full coverage on Vimta Labs Limited: - marketscreener.com

Vimta Labs Limited:  marketscreener.com

Vimta Labs Limited: - marketscreener.com

Click here to get full coverage on Vimta Labs Limited (NSE:VIMTALABS) Looks Interesting, And It's About To Pay A Dividend - simplywall.st

Vimta Labs Limited (NSE:VIMTALABS) Looks Interesting, And It's About To Pay A Dividend  simplywall.st

Vimta Labs Limited (NSE:VIMTALABS) Looks Interesting, And It's About To Pay A Dividend - simplywall.st

Click here to get full coverage on Tata Tech, Vimta Labs, Capital Small Finance Bank, GHCL Dividend Record Date: Last Day To Buy Shares To Qualify - NDTV Profit

Tata Tech, Vimta Labs, Capital Small Finance Bank, GHCL Dividend Record Date: Last Day To Buy Shares To Qualify  NDTV Profit

Tata Tech, Vimta Labs, Capital Small Finance Bank, GHCL Dividend Record Date: Last Day To Buy Shares To Qualify - NDTV Profit

Click here to get full coverage on Vimta Labs Limited (NSE:VIMTALABS) May Have Run Too Fast Too Soon With Recent 29% Price Plummet - simplywall.st

Vimta Labs Limited (NSE:VIMTALABS) May Have Run Too Fast Too Soon With Recent 29% Price Plummet  simplywall.st

Vimta Labs Limited (NSE:VIMTALABS) May Have Run Too Fast Too Soon With Recent 29% Price Plummet - simplywall.st

Click here to get full coverage on Vimta Labs schedules investor meet with Goldman Sachs - scanx.trade

Vimta Labs schedules investor meet with Goldman Sachs  scanx.trade

Vimta Labs schedules investor meet with Goldman Sachs - scanx.trade

Click here to get full coverage on Vimta Labs Q2 Revenue Hits ₹104.5 Cr, Up 22.3% YoY - HDFC Sky

Vimta Labs Q2 Revenue Hits ₹104.5 Cr, Up 22.3% YoY  HDFC Sky

Vimta Labs Q2 Revenue Hits ₹104.5 Cr, Up 22.3% YoY - HDFC Sky

Click here to get full coverage on Vimta Labs Q1 FY26 PAT climbs to Rs. 18.89 Cr - Indian Pharma Post

Vimta Labs Q1 FY26 PAT climbs to Rs. 18.89 Cr  Indian Pharma Post

Vimta Labs Q1 FY26 PAT climbs to Rs. 18.89 Cr - Indian Pharma Post

Click here to get full coverage on Vimta Labs Bets on Biologics To Drive the Next Phase of Growth - Moneylife

Vimta Labs Bets on Biologics To Drive the Next Phase of Growth  Moneylife

Vimta Labs Bets on Biologics To Drive the Next Phase of Growth - Moneylife

Click here to get full coverage on Vimta Labs Standalone March 2026 Net Sales at Rs 109.25 crore, up 15.68% Y-o-Y - Moneycontrol.com

Vimta Labs Standalone March 2026 Net Sales at Rs 109.25 crore, up 15.68% Y-o-Y  Moneycontrol.com

Vimta Labs Standalone March 2026 Net Sales at Rs 109.25 crore, up 15.68% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Smallcap stock soars 14% on heavy volumes, nears record high. Do you own? - Business Standard

Smallcap stock soars 14% on heavy volumes, nears record high. Do you own?  Business Standard

Smallcap stock soars 14% on heavy volumes, nears record high. Do you own? - Business Standard

Click here to get full coverage on Vimta Labs confirms no encumbrance on promoter shares in FY26 - scanx.trade

Vimta Labs confirms no encumbrance on promoter shares in FY26  scanx.trade

Vimta Labs confirms no encumbrance on promoter shares in FY26 - scanx.trade

Click here to get full coverage on Buy, Sell Or Hold: Trent, GAIL, IndiGo, Voltamp Transformers, Vimta Labs — Ask Profit - NDTV Profit

Buy, Sell Or Hold: Trent, GAIL, IndiGo, Voltamp Transformers, Vimta Labs — Ask Profit  NDTV Profit

Buy, Sell Or Hold: Trent, GAIL, IndiGo, Voltamp Transformers, Vimta Labs — Ask Profit - NDTV Profit

Click here to get full coverage on Is Vimta Labs Limited's (NSE:VIMTALABS) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st

Is Vimta Labs Limited's (NSE:VIMTALABS) Latest Stock Performance A Reflection Of Its Financial Health?  simplywall.st

Is Vimta Labs Limited's (NSE:VIMTALABS) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st

Click here to get full coverage on Vimta Labs Standalone December 2025 Net Sales at Rs 98.63 crore, up 11.43% Y-o-Y - Moneycontrol.com

Vimta Labs Standalone December 2025 Net Sales at Rs 98.63 crore, up 11.43% Y-o-Y  Moneycontrol.com

Vimta Labs Standalone December 2025 Net Sales at Rs 98.63 crore, up 11.43% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Vimta Labs FY26 Revenue Rises 19.5%; Dividend Declared - scanx.trade

Vimta Labs FY26 Revenue Rises 19.5%; Dividend Declared  scanx.trade

Vimta Labs FY26 Revenue Rises 19.5%; Dividend Declared - scanx.trade

Click here to get full coverage on Vimta Labs schedules AGM for June 25, 2026 - scanx.trade

Vimta Labs schedules AGM for June 25, 2026  scanx.trade

Vimta Labs schedules AGM for June 25, 2026 - scanx.trade

Click here to get full coverage on Vimta Labs to meet investors at Systematix forum on June 16 - scanx.trade

Vimta Labs to meet investors at Systematix forum on June 16  scanx.trade

Vimta Labs to meet investors at Systematix forum on June 16 - scanx.trade

Click here to get full coverage on Vimta Labs Q4 FY26: Strong Earnings, US Subsidiary Planned, Dividend Recommended - scanx.trade

Vimta Labs Q4 FY26: Strong Earnings, US Subsidiary Planned, Dividend Recommended  scanx.trade

Vimta Labs Q4 FY26: Strong Earnings, US Subsidiary Planned, Dividend Recommended - scanx.trade

Click here to get full coverage on Vimta Labs Q4 FY26 Earnings Call: Revenue Up 16.6%, EBITDA Margins at 37.6% - scanx.trade

Vimta Labs Q4 FY26 Earnings Call: Revenue Up 16.6%, EBITDA Margins at 37.6%  scanx.trade

Vimta Labs Q4 FY26 Earnings Call: Revenue Up 16.6%, EBITDA Margins at 37.6% - scanx.trade

Click here to get full coverage on Vimta Labs reschedules analyst meetings to March 31, adds CVC Partners meet - scanx.trade

Vimta Labs reschedules analyst meetings to March 31, adds CVC Partners meet  scanx.trade

Vimta Labs reschedules analyst meetings to March 31, adds CVC Partners meet - scanx.trade

Click here to get full coverage on Vimta Labs Board Recommends Re-appointment of Dr. S. P. Vasireddi as Executive Chairman for Five-Year Term - scanx.trade

Vimta Labs Board Recommends Re-appointment of Dr. S. P. Vasireddi as Executive Chairman for Five-Year Term  scanx.trade

Vimta Labs Board Recommends Re-appointment of Dr. S. P. Vasireddi as Executive Chairman for Five-Year Term - scanx.trade

Click here to get full coverage on Vimta Labs to invest Rs. 50 crores to Biologics CDMO business foray - Indian Pharma Post

Vimta Labs to invest Rs. 50 crores to Biologics CDMO business foray  Indian Pharma Post

Vimta Labs to invest Rs. 50 crores to Biologics CDMO business foray - Indian Pharma Post

Click here to get full coverage on Vimta Labs Reports Record Q1FY25-26 Revenue on Pharma, Export Demand; Maintains Growth Outlook, despite Margin Headwinds - Moneylife

Vimta Labs Reports Record Q1FY25-26 Revenue on Pharma, Export Demand; Maintains Growth Outlook, despite Margin Headwinds  Moneylife

Vimta Labs Reports Record Q1FY25-26 Revenue on Pharma, Export Demand; Maintains Growth Outlook, despite Margin Headwinds - Moneylife

Click here to get full coverage on VIMTALABS Stock Price and Chart — NSE:VIMTALABS - TradingView

VIMTALABS Stock Price and Chart — NSE:VIMTALABS  TradingView

VIMTALABS Stock Price and Chart — NSE:VIMTALABS - TradingView

Click here to get full coverage on VIMTA forays into Electrical and Electronics Products Testing - PR Newswire

VIMTA forays into Electrical and Electronics Products Testing  PR Newswire

VIMTA forays into Electrical and Electronics Products Testing - PR Newswire

Click here to get full coverage on Vimta Labs Ltd. Share Price Today | Vimta Labs Live NSE/BSE - Value Research

Vimta Labs Ltd. Share Price Today | Vimta Labs Live NSE/BSE  Value Research

Vimta Labs Ltd. Share Price Today | Vimta Labs Live NSE/BSE - Value Research

Click here to get full coverage on Thyrocare to acquire diagnostic and pathological services business of Vimta Labs - Indian Pharma Post

Thyrocare to acquire diagnostic and pathological services business of Vimta Labs  Indian Pharma Post

Thyrocare to acquire diagnostic and pathological services business of Vimta Labs - Indian Pharma Post

Click here to get full coverage on Vinod Upadhyay Appointed as Vice President – Human Resources at Vimta Labs Ltd - hrtoday.in

Vinod Upadhyay Appointed as Vice President – Human Resources at Vimta Labs Ltd  hrtoday.in

Vinod Upadhyay Appointed as Vice President – Human Resources at Vimta Labs Ltd - hrtoday.in

Click here to get full coverage on Vimta Labs - These 11 healthcare stocks have more than doubled investors' wealth in CY24 - The Economic Times

Vimta Labs - These 11 healthcare stocks have more than doubled investors' wealth in CY24  The Economic Times

Vimta Labs - These 11 healthcare stocks have more than doubled investors' wealth in CY24 - The Economic Times

Click here to get full coverage on Thyrocare to acquire Vimta Labs’ diagnostic business for ₹7 crore - BusinessLine

Thyrocare to acquire Vimta Labs’ diagnostic business for ₹7 crore  BusinessLine

Thyrocare to acquire Vimta Labs’ diagnostic business for ₹7 crore - BusinessLine

Click here to get full coverage on VIMTA Labs forays into electrical, electronics testing - BusinessLine

VIMTA Labs forays into electrical, electronics testing  BusinessLine

VIMTA Labs forays into electrical, electronics testing - BusinessLine

Click here to get full coverage on VIMTA LABS LIMITED Share Price Today - Live VIMTALABS Stock Price for NSE/BSE - Upstox

VIMTA LABS LIMITED Share Price Today - Live VIMTALABS Stock Price for NSE/BSE  Upstox

VIMTA LABS LIMITED Share Price Today - Live VIMTALABS Stock Price for NSE/BSE - Upstox

Click here to get full coverage on These 4 stocks hit 52-week highs, rallied up to 45% in a month - The Economic Times

These 4 stocks hit 52-week highs, rallied up to 45% in a month  The Economic Times

These 4 stocks hit 52-week highs, rallied up to 45% in a month - The Economic Times

Click here to get full coverage on Buy Vimta Labs at Rs 1153 - Market Trading Guide: Vimta Labs among 2 stock recommendations for Friday - The Economic Times

Buy Vimta Labs at Rs 1153 - Market Trading Guide: Vimta Labs among 2 stock recommendations for Friday  The Economic Times

Buy Vimta Labs at Rs 1153 - Market Trading Guide: Vimta Labs among 2 stock recommendations for Friday - The Economic Times

Click here to get full coverage on Vimta Labs Limited Appoints Mrs. Y Prameela Rani as Non- Executive Independent Director - marketscreener.com

Vimta Labs Limited Appoints Mrs. Y Prameela Rani as Non- Executive Independent Director  marketscreener.com

Vimta Labs Limited Appoints Mrs. Y Prameela Rani as Non- Executive Independent Director - marketscreener.com

Click here to get full coverage on Vimta Labs announces the Centre of Excellence for Bioassays at Confluence 2020 - ANI News

Vimta Labs announces the Centre of Excellence for Bioassays at Confluence 2020  ANI News

Vimta Labs announces the Centre of Excellence for Bioassays at Confluence 2020 - ANI News

Click here to get full coverage on Vimta Labs CSR Spending Report of Rs 1.16 Crore for FY 2025 - India CSR

Vimta Labs CSR Spending Report of Rs 1.16 Crore for FY 2025  India CSR

Vimta Labs CSR Spending Report of Rs 1.16 Crore for FY 2025 - India CSR

Click here to get full coverage on FSSAI, Vimta Labs set up national food lab at Navi Mumbai - FFOODS Spectrum

FSSAI, Vimta Labs set up national food lab at Navi Mumbai  FFOODS Spectrum

FSSAI, Vimta Labs set up national food lab at Navi Mumbai - FFOODS Spectrum

Click here to get full coverage on Vimta Labs surges 20% on heavy volumes - Business Standard

Vimta Labs surges 20% on heavy volumes  Business Standard

Vimta Labs surges 20% on heavy volumes - Business Standard

Click here to get full coverage on Vimta Labs to expand its network - Projects Today

Vimta Labs to expand its network  Projects Today

Vimta Labs to expand its network - Projects Today

Click here to get full coverage on Vimta Labs Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements - MarketsMojo

Vimta Labs Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements  MarketsMojo

Vimta Labs Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd is Rated Sell - MarketsMojo

Vimta Labs Ltd is Rated Sell  MarketsMojo

Vimta Labs Ltd is Rated Sell - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Surges 7.03% to Day's High of Rs 587 — Outperforms Healthcare Sector by 7.41 Percentage Points - MarketsMojo

Vimta Labs Ltd Surges 7.03% to Day's High of Rs 587 — Outperforms Healthcare Sector by 7.41 Percentage Points  MarketsMojo

Vimta Labs Ltd Surges 7.03% to Day's High of Rs 587 — Outperforms Healthcare Sector by 7.41 Percentage Points - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Shows Mildly Bullish Momentum Amid Technical Upgrades - MarketsMojo

Vimta Labs Ltd Shows Mildly Bullish Momentum Amid Technical Upgrades  MarketsMojo

Vimta Labs Ltd Shows Mildly Bullish Momentum Amid Technical Upgrades - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Technical Momentum Shifts Amid Mixed Market Signals - MarketsMojo

Vimta Labs Ltd Technical Momentum Shifts Amid Mixed Market Signals  MarketsMojo

Vimta Labs Ltd Technical Momentum Shifts Amid Mixed Market Signals - MarketsMojo

Click here to get full coverage on Vimta Labs Shares Surge 7% Following Strong Q4; Revenue Hits Record Highs - Trade Brains

Vimta Labs Shares Surge 7% Following Strong Q4; Revenue Hits Record Highs  Trade Brains

Vimta Labs Shares Surge 7% Following Strong Q4; Revenue Hits Record Highs - Trade Brains

Click here to get full coverage on Vimta Labs Ltd Hits Intraday Low Amid Price Pressure on 28 Jan 2026 - MarketsMojo

Vimta Labs Ltd Hits Intraday Low Amid Price Pressure on 28 Jan 2026  MarketsMojo

Vimta Labs Ltd Hits Intraday Low Amid Price Pressure on 28 Jan 2026 - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Surges 7.59% to Day's High of Rs 560.4 — Outperforms Sector by 3.39 Percentage Points - MarketsMojo

Vimta Labs Ltd Surges 7.59% to Day's High of Rs 560.4 — Outperforms Sector by 3.39 Percentage Points  MarketsMojo

Vimta Labs Ltd Surges 7.59% to Day's High of Rs 560.4 — Outperforms Sector by 3.39 Percentage Points - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Surges 7.19% to Day's High of Rs 497 — Outperforms Sector by 4.16 Percentage Points - MarketsMojo

Vimta Labs Ltd Surges 7.19% to Day's High of Rs 497 — Outperforms Sector by 4.16 Percentage Points  MarketsMojo

Vimta Labs Ltd Surges 7.19% to Day's High of Rs 497 — Outperforms Sector by 4.16 Percentage Points - MarketsMojo

Click here to get full coverage on Vimta Labs FY26 Revenue Jumps 19.5% Amid Profit Growth, Debt Cut - Whalesbook

Vimta Labs FY26 Revenue Jumps 19.5% Amid Profit Growth, Debt Cut  Whalesbook

Vimta Labs FY26 Revenue Jumps 19.5% Amid Profit Growth, Debt Cut - Whalesbook

Click here to get full coverage on Vimta Labs Sets May 6 Earnings Call to Review Q4 2025-26 Performance - Whalesbook

Vimta Labs Sets May 6 Earnings Call to Review Q4 2025-26 Performance  Whalesbook

Vimta Labs Sets May 6 Earnings Call to Review Q4 2025-26 Performance - Whalesbook

Click here to get full coverage on Vimta Labs Ltd Hits Intraday Low Amid Price Pressure on 29 Jan 2026 - MarketsMojo

Vimta Labs Ltd Hits Intraday Low Amid Price Pressure on 29 Jan 2026  MarketsMojo

Vimta Labs Ltd Hits Intraday Low Amid Price Pressure on 29 Jan 2026 - MarketsMojo

Click here to get full coverage on Vimta Labs Q3 FY26: Strong Profit Surge Masks Growing Valuation Concerns - MarketsMojo

Vimta Labs Q3 FY26: Strong Profit Surge Masks Growing Valuation Concerns  MarketsMojo

Vimta Labs Q3 FY26: Strong Profit Surge Masks Growing Valuation Concerns - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals - MarketsMojo

Vimta Labs Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals  MarketsMojo

Vimta Labs Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Surges 8.46% to Day's High of Rs 579.4 — Outperforms Sector by 10.14 Percentage Points - MarketsMojo

Vimta Labs Ltd Surges 8.46% to Day's High of Rs 579.4 — Outperforms Sector by 10.14 Percentage Points  MarketsMojo

Vimta Labs Ltd Surges 8.46% to Day's High of Rs 579.4 — Outperforms Sector by 10.14 Percentage Points - MarketsMojo

Click here to get full coverage on Vimta Labs Q2 FY26: Stellar 141% Profit Surge Masks Valuation Concerns - MarketsMojo

Vimta Labs Q2 FY26: Stellar 141% Profit Surge Masks Valuation Concerns  MarketsMojo

Vimta Labs Q2 FY26: Stellar 141% Profit Surge Masks Valuation Concerns - MarketsMojo

Click here to get full coverage on Vimta Labs Achieves All-Time High Stock Price, Signaling Strong Market Momentum - MarketsMojo

Vimta Labs Achieves All-Time High Stock Price, Signaling Strong Market Momentum  MarketsMojo

Vimta Labs Achieves All-Time High Stock Price, Signaling Strong Market Momentum - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Surges 7.3% to Day's High of Rs 399.9 — Outperforms Sensex Despite Sector Lag - MarketsMojo

Vimta Labs Ltd Surges 7.3% to Day's High of Rs 399.9 — Outperforms Sensex Despite Sector Lag  MarketsMojo

Vimta Labs Ltd Surges 7.3% to Day's High of Rs 399.9 — Outperforms Sensex Despite Sector Lag - MarketsMojo

Click here to get full coverage on Vimta Labs Reaches All-Time High Amid Strong Momentum and Sector Outperformance - MarketsMojo

Vimta Labs Reaches All-Time High Amid Strong Momentum and Sector Outperformance  MarketsMojo

Vimta Labs Reaches All-Time High Amid Strong Momentum and Sector Outperformance - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Downgraded to Sell Amid Mixed Financials and Technical Weakness - MarketsMojo

Vimta Labs Ltd Downgraded to Sell Amid Mixed Financials and Technical Weakness  MarketsMojo

Vimta Labs Ltd Downgraded to Sell Amid Mixed Financials and Technical Weakness - MarketsMojo

Click here to get full coverage on Vimta Labs Ltd Hits Intraday High with 9.24% Surge on 1 Feb 2026 - MarketsMojo

Vimta Labs Ltd Hits Intraday High with 9.24% Surge on 1 Feb 2026  MarketsMojo

Vimta Labs Ltd Hits Intraday High with 9.24% Surge on 1 Feb 2026 - MarketsMojo

Click here to get full coverage on From Rs 30 to Rs 1,000! Why this multibagger stock is showing 50% fall today in some apps today - Business Today

From Rs 30 to Rs 1,000! Why this multibagger stock is showing 50% fall today in some apps today  Business Today

From Rs 30 to Rs 1,000! Why this multibagger stock is showing 50% fall today in some apps today - Business Today

Click here to get full coverage on Thyrocare to acquire Vimta Labs’ diagnostic and pathological services biz - financialexpress.com

Thyrocare to acquire Vimta Labs’ diagnostic and pathological services biz  financialexpress.com

Thyrocare to acquire Vimta Labs’ diagnostic and pathological services biz - financialexpress.com

Click here to get full coverage on VIMTA forays into Electrical and Electronics Products Testing - Passionate In Marketing

VIMTA forays into Electrical and Electronics Products Testing  Passionate In Marketing

VIMTALABS

Price Chart

Key Statistics

Technicals

About VIMTALABS

Latest News

Vimta Labs Limited: - marketscreener.com

Vimta Labs Limited (NSE:VIMTALABS) Looks Interesting, And It's About To Pay A Dividend - simplywall.st

Tata Tech, Vimta Labs, Capital Small Finance Bank, GHCL Dividend Record Date: Last Day To Buy Shares To Qualify - NDTV Profit

Advanced Charts

Top Gainers

Top Losers